BIOLINERX     Print Page  Close Window

SEC filings
6-K
BIOLINERX LTD. filed this Form 6-K on 08/11/2016
Entire Document
 

 
BioLineRx Ltd.
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION
(UNAUDITED)

   
December 31,
   
June 30,
 
   
2015
   
2016
 
   
in USD thousands
 
Assets
           
CURRENT ASSETS
           
Cash and cash equivalents
   
5,544
     
3,877
 
Short-term bank deposits
   
42,119
     
37,945
 
Prepaid expenses
   
229
     
324
 
Other receivables
   
291
     
548
 
Total current assets
   
48,183
     
42,694
 
                 
NON-CURRENT ASSETS
               
Long-term prepaid expenses
   
58
     
54
 
Property and equipment, net
   
2,909
     
2,770
 
Intangible assets, net
   
152
     
162
 
Total non-current assets
   
3,119
     
2,986
 
Total assets
   
51,302
     
45,680
 
                 
Liabilities and equity
               
CURRENT LIABILITIES
               
Current maturities of long-term bank loan
   
93
     
93
 
Accounts payable and accruals:
               
Trade
   
1,910
     
1,732
 
Other
   
1,137
     
980
 
Total current liabilities
   
3,140
     
2,805
 
NON-CURRENT LIABILITIES
               
Long-term bank loan, net of current maturities
   
344
     
296
 
Warrants
   
208
     
15
 
Total non-current liabilities
   
552
     
311
 
COMMITMENTS AND CONTINGENT LIABILITIES
               
Total liabilities
   
3,692
     
3,116
 
                 
EQUITY
               
Ordinary shares
   
1,455
     
1,459
 
Share premium
   
196,201
     
197,858
 
Other comprehensive loss
   
(1,416
)
   
(1,416
)
Capital reserve
   
10,735
     
11,251
 
Accumulated deficit
   
(159,365
)
   
(166,588
)
Total equity
   
47,610
     
42,564
 
Total liabilities and equity
   
51,302
     
45,680
 
 
The accompanying notes are an integral part of these condensed financial statements.

1